We should be very wary about the DEA allowing regulation and marketing of pharmaceutical products containing plant-derived THC. “[M]arijuana has no scientifically proven medical value.” So stated the United States Drug Enforcement Administration (DEA) on...
BACKGROUND Chronic neuropathic pain affects 1%-2% of the adult population and is often refractory to standard pharmacologic treatment. Patients with chronic pain have reported using smoked cannabis to relieve pain, improve sleep and improve mood. METHODS: Adults with...
[yframe url=’http://www.youtube.com/watch?v=ZI2VT2kOfnM’]
Speaking on behalf of medical marijuana patients everywhere; Montel Williams faces the Los Angeles city council as the vote to regulate dispensaries. Worth mentioning… Montel talks about the effects of butane on people with nervous system disorders – as a...
Preliminary results of clinical research conducted in the UK and in Switzerland show that cannabis and THC are able to reduce hyperactivity of the bladder in patients with multiple sclerosis and spinal cord injury. The Swiss study conducted at the REHAB in Basel under...
A six-week, placebo-controlled clinical trial of an oral spray drug derived from whole cannabis plants (Sativex® — GW Pharmaceuticals, Salisbury, UK) involving 189 individuals with multiple sclerosis showed positive changes in a self-reported measurement of...
